Cargando…

The novel NO redox sibling, nitroxyl (HNO), prevents cardiomyocyte hypertrophy and superoxide generation via cGMP

Detalles Bibliográficos
Autores principales:	Ritchie, Rebecca, Irvine, Jennifer, Gossain, Swati, Love, Jane, Horowitz, John, Kemp-Harper, Barbara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313372/ http://dx.doi.org/10.1186/1471-2210-9-S1-P58

Ejemplares similares

Nitroxyl (HNO) Stimulates Soluble Guanylyl Cyclase to Suppress Cardiomyocyte Hypertrophy and Superoxide Generation
por: Lin, Eliane Q., et al.
Publicado: (2012)

The nitroxyl donor isopropylamine-NONOate elicits soluble guanylyl cyclase-dependent antihypertrophic actions: comparison of the potential therapeutic advantages of HNO over NO•
por: Ritchie, Rebecca, et al.
Publicado: (2013)

Nitroxyl, the novel redox sibling of NO, suppresses cerebrovascular NADPH oxidase
por: Kemp-Harper, Barbara, et al.
Publicado: (2009)

cGMP and cardiac hypertrophy
por: Perera, Ruwan K, et al.
Publicado: (2015)

Comparison of Reductive Ligation‐Based Detection Strategies for Nitroxyl (HNO) and S‐Nitrosothiols
por: Miao, Zhengrui, et al.
Publicado: (2016)

Comparison of Reductive Ligation‐Based Detection Strategies for Nitroxyl (HNO) and S‐Nitrosothiols
por: Miao, Zhengrui, et al.
Publicado: (2016)

Mechanisms Associated to Nitroxyl (HNO)-Induced Relaxation in the Intestinal Smooth Muscle
por: Gastreich-Seelig, Mirko, et al.
Publicado: (2020)

Oxidant sensor in the cGMP-binding pocket of PKGIα regulates nitroxyl-mediated kinase activity
por: Donzelli, Sonia, et al.
Publicado: (2017)

Para-Substituted O-Benzyl Sulfohydroxamic Acid Derivatives as Redox-Triggered Nitroxyl (HNO) Sources
por: Long, Yueming, et al.
Publicado: (2022)

Dual Mechanisms of HNO Generation by a Nitroxyl Prodrug of the Diazeniumdiolate (NONOate) Class
por: Andrei, Daniela, et al.
Publicado: (2010)

Nitroxyl (HNO) targets phospholamban cysteines 41 and 46 to enhance cardiac function
por: Keceli, Gizem, et al.
Publicado: (2019)

Involvement of TRPA1 receptors in meningeal blood flow induced by formation of nitroxyl (NO-/HNO)
por: Dux, M, et al.
Publicado: (2013)

Induction of caveolin-3/eNOS complex by nitroxyl (HNO) ameliorates diabetic cardiomyopathy
por: Sun, Hai-Jian, et al.
Publicado: (2020)

The Soluble Guanylyl Cyclase Activator Bay 58-2667 Selectively Limits Cardiomyocyte Hypertrophy
por: Irvine, Jennifer C., et al.
Publicado: (2012)

Direct visualization of cGMP microdomains in adult cardiomyocytes
por: Subramanian, Hariharan, et al.
Publicado: (2015)

The Effects of Nitroxyl (HNO) on Soluble Guanylate Cyclase Activity: INTERACTIONS AT FERROUS HEME AND CYSTEINE THIOLS
por: Miller, Thomas W., et al.
Publicado: (2009)

A Fast and Selective Near-Infrared Fluorescent Sensor for Multicolor Imaging of Biological Nitroxyl (HNO)
por: Wrobel, Alexandra T., et al.
Publicado: (2014)

Nitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic Properties
por: Shoman, Mai E., et al.
Publicado: (2016)

cGMP kinase I, cardiac hypertrophy and PDE inhibition
por: Patrucco, Enrico, et al.
Publicado: (2011)

Nitroxyl: A Novel Strategy to Circumvent Diabetes Associated Impairments in Nitric Oxide Signaling
por: Velagic, Anida, et al.
Publicado: (2020)

Retracted: Nitroxyl (HNO): A Reduced Form of Nitric Oxide with Distinct Chemical, Pharmacological, and Therapeutic Properties
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2016)

FRET-based cyclic GMP biosensors measure low cGMP concentrations in cardiomyocytes and neurons
por: Calamera, Gaia, et al.
Publicado: (2019)

Cover Picture: Comparison of Reductive Ligation‐Based Detection Strategies for Nitroxyl (HNO) and S‐Nitrosothiols (ChemistryOpen 2/2016)
por: Miao, Zhengrui, et al.
Publicado: (2016)

PDE3 is the major cGMP-PDE in adult mouse ventricular cardiomyocytes
por: Götz, Konrad R, et al.
Publicado: (2013)

NO/cGMP signalling in platelets
por: Schinner, Elisabeth, et al.
Publicado: (2009)

Analysis of cGMP signalling with transgenic mice expressing FRET-based cGMP sensors
por: Wen, Lai, et al.
Publicado: (2013)

Transient kinetics of a cGMP-dependent cGMP-specific phosphodiesterase from Dictyostelium discoideum
Publicado: (1984)

Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling
por: Mullershausen, Florian, et al.
Publicado: (2003)

β(3)-Adrenoceptor redistribution impairs NO/cGMP/PDE2 signalling in failing cardiomyocytes
por: Schobesberger, Sophie, et al.
Publicado: (2020)

Cardioprotective actions of nitroxyl donor Angeli's salt are preserved in the diabetic heart and vasculature in the face of nitric oxide resistance
por: Velagic, Anida, et al.
Publicado: (2022)

PDE5 says NO to cGMP
por: LeBrasseur, Nicole
Publicado: (2003)

cGMP steers axons home
por: LeBrasseur, Nicole
Publicado: (2002)

A novel pathway of cGMP
por: Kuhn, Michaela, et al.
Publicado: (2011)

The role of cGMP and PKG in cardioprotection
por: Downey, James M, et al.
Publicado: (2009)

NO-cGMP signalling and cancer therapy
por: Bian, Ka, et al.
Publicado: (2013)

Role of cGMP in fat and metabolism
por: Pfeifer, Alexander, et al.
Publicado: (2013)

cGMP Signaling in Photoreceptor Degeneration
por: Li, Shujuan, et al.
Publicado: (2023)

Inhibition of the TGFβ signalling pathway by cGMP and cGMP‐dependent kinase I in renal fibrosis
por: Schinner, Elisabeth, et al.
Publicado: (2017)

cGMP: a unique 2nd messenger molecule – recent developments in cGMP research and development
por: Friebe, Andreas, et al.
Publicado: (2019)

Concerted Regulation of cGMP and cAMP Phosphodiesterases in Early Cardiac Hypertrophy Induced by Angiotensin II
por: Mokni, Walid, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_1f62ge7tosv09s9bmk2kcvn2v7